What Previous Training Is Required to Be an Eye Movement Desensitization and Reprocessing(EMDR) Therapist

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

EMDR therapy is a deep form of psychotherapy that helps patients overcome trauma. Most of the trauma is triggered by difficult memories and experiences in life, while therapy often works by recalling those events. In other words, EMDR is suitable for healing from depressive episodes, anxiety and even PTSD. Its effectiveness has made it a […]

The post What Previous Training Is Required to Be an Eye Movement Desensitization and Reprocessing(EMDR) Therapist appeared first on Medical News Bulletin.

Oku Digital Health uses eye care to detect diseases earlier

NEW ORLEANS — Oku Digital Health, which was recently launched from Topcon Healthcare, will use a network of more than 10,000 healthcare locations for early disease detection through routine eye exams, according to a press release.
Oculomics is the use of ocular biomarkers to monitor for development of diseases.
{{VIDEO}}
At the American Academy of Ophthalmology meeting, Ali Tafreshi, CEO of Oku, told Healio that the company’s primary goal is to use this emerging field to address the healthcare cost crisis in the U.S. and globally.
“We’ve been planting the seeds for what we call ‘healthcare from

AI ‘may offer an efficient way’ to detect colorectal neoplasia

NASHVILLE, Tenn. — Two machine learning models demonstrated high accuracy in identifying adenomas and sessile serrated lesions, although more research is needed to determine their long-term performance, according to study results.
Data presented at ACG Annual Scientific Meeting showed that while a random forest model exhibited higher sensitivity, it also had a higher false-positive rate.
“Accurate reporting of ADR is essential for assessing colonoscopy quality and ultimately improving colorectal cancer prevention,” Vignesh Krishnan Nagesh, MBBS, a hospitalist at Aikens Regional Medical Centers,

ACOG expands guidance on treatment for menopause symptoms

ACOG has expanded its recommendations for managing menopause symptoms, including more information about certain symptoms and the timing of treatment.
“Perimenopause and menopause are normal and expected phases of life, but symptoms such as hot flashes, sleep disturbances and vaginal symptoms can have a profound effect on health, quality of life and daily functioning,” ACOG President Camille A. Clare, MD, MPH, CPE, FACOG, said during a press briefing.
According to Clare, women spend roughly one-third of their lives in the postmenopausal stage, “and untreated symptoms can affect physical health,

Pruritus declined within 2 weeks with volixibat in PSC

NASHVILLE, Tenn. — Patients with primary sclerosing cholangitis and moderate to severe pruritus reported significantly lower cholestatic pruritus and sleep disturbance with volixibat than with placebo, VISTAS trial data showed.
Patients who received volixibat (Mirum Pharmaceuticals), an investigational ileal bile acid transporter (IBAT) inhibitor, also had significantly lower serum bile acid levels and reduced fatigue, noted a presenter at ACG Annual Scientific Meeting.
“[This trial] is the largest interventional study investigating the efficacy and safety of IBAT inhibition in patients with

Faricimab significantly resolves macular edema at 6 months

Faricimab showed a positive treatment effect for up to 6 months in patients with macular edema due to retinal vein occlusion, according to data published in Ophthalmology and Therapy.
“Due to the very recent approval of faricimab for [macular edema] secondary to [retinal vein occlusion], and consequent restrictions on cost reimbursement by health systems, real-world data have been limited so far, and the first reports have only recently begun to emerge,” Katharina Heck, FMH, FEBO, of the Vista Augenklinik Binningen in Switzerland, and colleagues wrote.
For a real-world look at

Verily Health, Bausch + Lomb partner to bring dry eye care to app

NEW ORLEANS — Verily Health has partnered with Bausch + Lomb to expand Verily Me, its consumer health app, into eye health for the first time.
The launch adds personalized risk and symptom education, an AI-guided symptom conversation with AI agent “Vi,” and an overview of treatment options for dry eye disease. An estimated 150 million U.S. adults experience occasional or frequent dry eye symptoms, and about 38 million live with diagnosed dry eye disease.
{{VIDEO}}
“This is a disease that affects tens of millions of people, and there's a disconnect sometimes between what people are diagnosed with

Q&A: Best practices for evaluating joint pain in primary care

Older adults with inflammatory arthritis often face delayed diagnosis, but primary care providers can be the first step to relief, according to an expert.
“Arthritis is a leading cause of pain and disability that affects nearly one-third” of older adults in the U.S. — those aged 65 years or older, Una E. Makris, MD, MSc, chief of the rheumatology section at the VA San Diego Healthcare System and a clinical professor at the University of California San Diego’s Division of Rheumatology, Autoimmunity & Inflammation, and colleagues wrote in JAMA Internal Medicine.
Osteoarthritis is the most

Lebrikizumab relieves ‘debilitating’ symptoms of hand, foot dermatitis in phase 3 study

Lebrikizumab monotherapy improved atopic hand and foot dermatitis and the itch, pain and quality of life measures associated with it, according to data presented at the European Academy of Dermatology and Venerology Congress.
Atopic hand and foot dermatitis is a common, recalcitrant and debilitating manifestation of eczema driven by an overexpression of interleukin-13, according to the late-breaking presentation. Though confined to small areas of the body, atopic hand and foot dermatitis can severely impact a patient’s quality of life, according to Patrick M. Brunner, MD, MSc, professor of

Obesity linked to lower mortality risk in dementia

Among people with dementia, having overweight or obesity at the time of diagnosis was associated with a lower risk for mortality, according to research published in the Journal of Alzheimer’s Disease.
The findings are observational and should not be used as the basis for clinical interventions, Virginia Chang, MD, associate professor of social and behavioral sciences at the NYU School of Global Public Health, and colleagues wrote.
However, the results can provide meaningful prognostic information for survival, she said
“Those who are overweight or obese have a lower mortality risk,” Chang told